In a murine transplantable tumor model, the removal of TCPTP from tumor cells led to the amplification of IFNγ-mediated effects on antigen presentation and growth inhibition, thus improving the sensitivity of cancer cells to immunotherapy and blocking cancer progression [102]. The gene discussed is IFNG; the disease is neoplasm.